32.54
BATS BZX Real-Time Price
As of 11:29am ET
 -0.48 / -1.45%
Today’s Change
31.54
Today|||52-Week Range
47.82
-23.09%
Year-to-Date
AbbVie Permits US Sale of Sandoz's Humira Biosimilar
Oct 12 / GuruFocus News - Paid Partner Content
Generic-Drugs Stock Outlook: No Respite from Pricing Issues
Oct 08 / Zacks.com - Paid Partner Content
AbbVie Settles With Novartis to Delay Humira Biosimilar in US
Oct 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close33.02
Today’s open33.01
Day’s range32.53 - 33.02
Volume105,862
Average volume (3 months)4,418,836
Market cap$17.0B
Data as of 11:29am ET, 10/18/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+1.97%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+7.06%
P/E ratio38.0
Price/Sales1.91
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.16-0.15%
INCYIncyte Corp-0.41-0.63%
SGENSeattle Genetics Inc-1.26-1.69%
PRGOPerrigo Company PLC-0.79-1.07%
Data as of 11:29am ET, 10/18/2018

Financials

Next reporting dateNovember 1, 2018
EPS forecast (this quarter)$1.21
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts